Literature DB >> 2995096

Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information.

C Caron de Fromentel, P C Nardeux, T Soussi, C Lavialle, S Estrade, G Carloni, K Chandrasekaran, R Cassingena.   

Abstract

The epithelial HBL-100 cell line was established in vitro from milk of an apparently healthy woman. It exhibits characteristics of transformation from the very beginning and evolves during in vitro maintenance, until becoming tumorigenic in nude mice. This immortal cell line represents a useful model for studying the progression of human epithelial cells toward malignancy. In the course of our investigations we detected a 94K protein in HBL-100 cells obtained from four different sources. This protein is shown to be indistinguishable from the SV40 large T-antigen on the basis of: Recognition by polyclonal and different monoclonal antibodies. Partial peptide map analysis. Specific binding capacity to the SV40 DNA origin of replication. The presence of a tandemly integrated SV40 genome is demonstrated by Southern blotting. Successful rescue of SV40 DNA by fusion with permissive COS-7, but not CV-1 cells, indicates that the SV40 T-antigen from HBL-100 cells is defective in a function(s) essential to the replication of the viral DNA. The possible origin of the SV40 genetic information that we have detected in HBL-100 cells and the implications of this finding on studies involving this cell line are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995096     DOI: 10.1016/0014-4827(85)90238-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

Authors:  O W Petersen; L Rønnov-Jessen; A R Howlett; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

3.  Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Authors:  Y Jin; X L Xu; M C Yang; F Wei; T C Ayi; A M Bowcock; R Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  DNA-binding properties of the major structural protein of simian virus 40.

Authors:  T Soussi
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.

Authors:  P Briand; O W Petersen; B Van Deurs
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

6.  Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR.

Authors:  G Sliutz; H Eder; H Koelbl; C Tempfer; L Auerbach; C Schneeberger; C Kainz; R Zeillinger
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.

Authors:  M J Pilat; J K Christman; S C Brooks
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

Authors:  A M Davidoff; J D Iglehart; J R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.

Authors:  A Vazquez-Martin; R Colomer; J Brunet; R Lupu; J A Menendez
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

10.  Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.

Authors:  A de Cupis; D Noonan; P Pirani; A Ferrera; L Clerico; R E Favoni
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.